Sort
50,496 grants matching “lung cancer”
Project 4:High Capacity Polymeric Micelle Therapeutics for Lung Cancer
$453,374Alexander V Kabanov · Univ Of North Carolina Chapel Hill · U54 · FY2018 · CA
Combined Cancer Therapy with RF Ablation and Drug-Loaded Nanopreparations
$453,320S. Nahum Goldberg · Northeastern University · U54 · FY2010 · CA
Discovery and optimization of novel mutant-selective allosteric inhibitors of EGFR T790M
$453,318Michael J Eck · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Pannoramic 250 BF Flash Tissue Microarray system
$453,300Kelli L. Boyd · Vanderbilt University · S10 · FY2014 · OD
Role of BMDCs in Solid Tumor Growth and Relapse
$453,295Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2009 · CA
Smoking and Cancer-Related Health Disparities among Sexual and Gender Minority Adults
$453,292Philip T Veliz · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Lung cancer heterogeneity and its impact on drug resistance.
$453,272Steven J Altschuler · Ut Southwestern Medical Center · R01 · FY2011 · CA
Virginia Mason Community Clinical Oncology Program
$453,250Jacqueline Vuky · Benaroya Research Inst At Virginia Mason · U10 · FY2008 · CA
The Role of Schwann Cells in the Progression of Melanoma
$453,195Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Role of BMDCs in Solid Tumor Growth and Relapse
$453,187Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2010 · CA
SCH: INT: Harnessing the Power of Technology: MOMBA for Postpartum Smoking
$453,186Megan Veenema Smith · Yale University · R01 · FY2016 · CA
The impact of senescence on immune memory
$453,163Laura Haynes · University Of Connecticut Sch Of Med/Dnt · R21 · FY2023 · AG
Integration of Mechanical and Soluble Signaling in Tumor Angiogenesis
$453,140Charles K Thodeti · Northeast Ohio Medical University · R15 · FY2016 · CA
Project 3
$453,113David L Spector · Cold Spring Harbor Laboratory · P01 · FY2016 · CA
Training in Comparative Lung Biology and Medicine
$453,101Reen Wu · University Of California At Davis · T32 · FY2016 · HL
Personalized radiation therapy through functional lung avoidance and response-adaptive dose escalation: utilizing multimodal molecular imaging to improve the therapeutic ratio
$453,066Stephen R. Bowen · University Of Washington · R01 · FY2016 · CA
Heparan Sulfate--a Novel Target for Cancer Therapeutics
$453,041University Of California San Diego · U01 · FY2004 · CA
Mechanism of Chronic Alcohol Consumption-induced Cancer-Associated Cachexia
$453,000Hui Zhang · Washington State University · R15 · FY2016 · AA
NGS-based analysis of mutation signatures during the translesion synthesis
$453,000Tomohiko Sugiyama · Ohio University Athens · R15 · FY2020 · ES
Liver Radioprotection by Systemic of Regional Amifostine
$452,949University Of Michigan At Ann Arbor · R01 · FY2005 · CA
Prospective validation of a multi-marker prostate cancer prediction model
$452,928Hans Gãsta Lilja · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development
$452,903Humam Kadara · University Of Tx Md Anderson Can Ctr · U01 · FY2022 · CA
Core B: Organoid Core
$452,832Calvin J Kuo · Stanford University · U19 · FY2024 · AI
Antidotes against HCI-induced chronic lung injury
$452,829John D. Catravas · Old Dominion University · U01 · FY2021 · ES
Characterization of growth factor-coupled signaling
$452,811Richard A. Cerione · Cornell University · R01 · FY2013 · GM